Human/JJ
CD4/NN
lymphocytes/NNS
specifically/RB
recognize/VBP
a/DT
peptide/NN
representing/VBG
the/DT
fusion/NN
region/NN
of/IN
the/DT
hybrid/NN
protein/NN
pml/RAR/NN
alpha/NN
present/JJ
in/IN
acute/JJ
promyelocytic/JJ
leukemia/NN
cells/NNS
./.

Fusion/NN
proteins/NNS
present/JJ
in/IN
leukemic/JJ
cells/NNS
frequently/RB
contain/VBP
a/DT
new/JJ
amino/NN
acid/NN
at/IN
the/DT
fusion/NN
point/NN
./.
=====
We/PRP
tested/VBD
whether/IN
a/DT
peptide/NN
(/(
BCR1/25/NN
)/)
encompassing/VBG
the/DT
fusion/NN
region/NN
of/IN
the/DT
hybrid/NN
molecule/NN
pml/RAR/NN
alpha/NN
,/,
which/WDT
is/VBZ
selectively/RB
expressed/VBN
by/IN
acute/JJ
promyelocytic/JJ
leukemia/NN
(/(
APL/NN
)/)
cells/NNS
,/,
can/MD
be/VB
recognized/VBN
by/IN
human/JJ
T/NN
lymphocytes/NNS
in/FW
vitro/FW
./.
=====
CD4+/JJ
lymphocytes/NNS
,/,
at/IN
both/CC
polyclonal/JJ
and/CC
clonal/JJ
level/NN
,/,
recognized/VBD
peptide/NN
BCR1/25/NN
in/IN
an/DT
HLA-DR/NN
--/:
restricted/JJ
fashion/NN
on/IN
presentation/NN
by/IN
autologous/JJ
antigen-presenting/JJ
cell/NN
(/(
APC/NN
)/)
or/CC
by/IN
APC/NN
expressing/VBG
the/DT
HLA-DR11/NN
restricting/NN
molecule/NN
./.
=====
Control/NN
peptides/NNS
corresponding/VBG
to/TO
the/DT
normal/JJ
pml/NN
and/CC
RAR/NN
alpha/NN
proteins/NNS
were/VBD
not/RB
recognized/VBN
./.
=====
One/CD
clone/NN
(/(
DEG5/NN
)/)
also/RB
exerted/VBD
a/DT
high/JJ
and/CC
specific/JJ
cytotoxicity/NN
against/IN
autologous/JJ
cells/NNS
pulsed/VBN
with/IN
BCR1/25/NN
./.
=====
The/DT
autologous/JJ
DE/NN
LCL/NN
containing/VBG
a/DT
transduced/VBN
pml/RAR/NN
alpha/NN
fusion/NN
gene/NN
and/CC
expressing/VBG
a/DT
bcr1/NN
type/NN
of/IN
the/DT
pml/RAR/NN
alpha/NN
hybrid/NN
protein/NN
induced/VBD
the/DT
proliferation/NN
of/IN
DE/NN
anti-BCR1/25/CD
T/NN
cell/NN
clones/NNS
./.
=====
It/PRP
is/VBZ
concluded/VBN
that/IN
the/DT
bcr1/NN
type-pml/RAR/NN
alpha/NN
fusion/NN
protein/NN
of/IN
APL/NN
contains/VBZ
an/DT
antigenic/JJ
site/NN
,/,
absent/JJ
from/IN
the/DT
normal/JJ
parent/NN
molecules/NNS
and/CC
recognized/VBN
by/IN
human/JJ
CD4+/JJ
lymphocytes/NNS
./.